Loading clinical trials...
Loading clinical trials...
Electrophysiological Biomarkers During Invasive Monitoring of Mesial Temporal Lobe Epilepsy Patients.
Conditions
Interventions
Asynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation device
Locations
1
United States
Epilepsy monitoring unit (EMU) at Emory University Hospital
Atlanta, Georgia, United States
Start Date
November 30, 2021
Primary Completion Date
December 16, 2021
Completion Date
December 16, 2021
Last Updated
March 5, 2024
NCT05608408
NCT06558864
NCT02383407
Lead Sponsor
Emory University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions